About Peginterferon beta-1a (63 ug/0.5ml + 94ug/0.5ml)
            
            Class:|Immunomodulator, Interferon  
Use:|Treatment of relapsing forms of multiple sclerosis (MS)  
Adult dose:|Starting dose: 63 µg subcutaneously on day 1, 94 µg on day 15, and 125 µg on day 29 and every 14 days thereafter  
Pediatric dose:|Safety and efficacy not established in pediatric patients  
Side effects:|Flu-like symptoms, injection site reactions, headache, myalgia, fever, chills, nausea, fatigue  
Contraindications:|Hypersensitivity to interferon beta or peginterferon, or any compon
         
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.